How Does 11-Beta Deficiency Differ From 21-Hydroxylase CAH?
At a Glance
In CAH, 21-hydroxylase deficiency often causes salt loss and low blood pressure, while 11-beta deficiency can cause high blood pressure from excess DOC. 17-alpha deficiency also causes high blood pressure but reduces sex hormones; hormone tests distinguish the variants and guide treatment.
In this answer
5 sections
Congenital Adrenal Hyperplasia (CAH) is a group of genetic conditions that affect the adrenal glands. In over 90% of cases, CAH is caused by a missing enzyme called 21-hydroxylase [1]. However, in about 5% to 8% of people with CAH, the condition is caused by a deficiency in a different enzyme known as 11-beta hydroxylase (CYP11B1) [2]. While classic 21-hydroxylase deficiency often causes salt loss and dangerously low blood pressure, 11-beta hydroxylase deficiency can lead to the opposite problem: high blood pressure (hypertension) [3][1].
21-Hydroxylase vs. 11-Beta Hydroxylase Deficiency
To understand the difference, it helps to picture the adrenal glands as a factory assembly line.
In 21-hydroxylase deficiency (the most common form of CAH), a block early in the assembly line prevents the production of cortisol and aldosterone (a hormone that helps your body hold onto salt) [1]. In its most severe “classic salt-wasting” form, this puts patients at risk for life-threatening salt-wasting crises and requires salt-retaining medications [1]. (There are also simple-virilizing and milder nonclassic forms of 21-hydroxylase deficiency that may not cause salt-wasting [4]).
In 11-beta hydroxylase deficiency, the block happens further down the assembly line. While cortisol production is still impaired, the body creates a backlog of a different chemical called 11-deoxycorticosterone (DOC) [3]. DOC acts similarly to aldosterone, causing the body to retain too much salt and water. This backlog of DOC is what frequently causes high blood pressure and low potassium levels (hypokalemia) in 11-beta hydroxylase deficiency [3][5]. However, the severity varies depending on residual enzyme activity, and some individuals may have normal blood pressure or potassium levels [6]. High blood pressure is often completely symptomless, meaning home monitoring and lab tests are necessary rather than waiting for symptoms like headaches or dizziness [7].
Despite these differences in blood pressure and salt balance, both conditions share a similar backlog of androgens (hormones made in higher amounts in typical male puberty) [2][1]. This excess androgen production can lead to early puberty and rapid bone growth in childhood for any sex, and variations in the development of external genitals for individuals with 46,XX chromosomes (assigned female at birth) [2][1].
Diagnosing the Exact Enzyme
Because both of these CAH variants cause excess androgens, they can look very similar at birth or in early childhood [2]. Standard newborn screening looks for a chemical marker called 17-OHP, which is highly elevated in 21-hydroxylase deficiency [5]. However, newborn screening is primarily designed for 21-hydroxylase deficiency and may miss 11-beta deficiency, or 17-OHP can be mildly elevated, leading to potential confusion [8].
To tell them apart, doctors look for specific biochemical “fingerprints.” A blood test showing high levels of a chemical called 11-deoxycortisol strongly points to 11-beta hydroxylase deficiency [8]. Diagnosis usually integrates a pattern of tests (including 11-deoxycortisol, DOC, 17-OHP, and adrenal androgens) alongside clinical signs [9]. Genetic testing can help support the diagnosis of exactly which enzyme is affected, though it requires careful interpretation by a specialist [10][11].
Another Rare Variant: 17-Alpha Hydroxylase Deficiency
There is another rare form of CAH caused by a missing enzyme called 17-alpha hydroxylase (CYP17A1). Like 11-beta deficiency, this variant causes a backlog of DOC, which can lead to high blood pressure and low potassium in many patients [12][13].
However, 17-alpha hydroxylase deficiency is unique because it impairs the body’s ability to produce sex steroids (both androgens and estrogens) [12]. Residual enzyme activity produces variable phenotypes, but instead of experiencing excess androgens, individuals with this rare variant often experience delayed puberty, a lack of menstrual periods (primary amenorrhea) in those with 46,XX chromosomes, or undervirilized or typically female external genitalia in those with 46,XY chromosomes [14][13][12].
Comparing the Types of CAH
| Feature | 21-Hydroxylase Deficiency (Classic) | 11-Beta Hydroxylase Deficiency | 17-Alpha Hydroxylase Deficiency |
|---|---|---|---|
| Enzyme Defect | CYP21A2 | CYP11B1 | CYP17A1 |
| Cortisol Levels | Low | Low | Low |
| Aldosterone / DOC | Low Aldosterone (Salt-wasting) | High DOC | High DOC |
| Blood Pressure / Potassium | Low BP, High Potassium | High BP, Low Potassium | High BP, Low Potassium |
| Androgens / Sex Steroids | High (Excess Androgens) | High (Excess Androgens) | Low (Deficient Sex Steroids) |
| Key Diagnostic Marker | 17-OHP | 11-deoxycortisol | Low sex steroids, High DOC |
Managing Your Specific Condition
The core goal of treatment in classic CAH is replacing the inadequate cortisol and suppressing the brain’s overproduction of a signal called ACTH, which in turn reduces the excess adrenal androgens and DOC [15]. This is typically achieved with glucocorticoid medications (like hydrocortisone or dexamethasone) [15]. While classic forms of CAH require lifelong glucocorticoid treatment, milder nonclassic forms may not always require ongoing medication; your endocrinologist will determine your specific needs [15].
For 11-beta hydroxylase deficiency: Your doctor will closely monitor your blood pressure and potassium levels. While individuals with classic salt-wasting 21-hydroxylase deficiency often take a medication called fludrocortisone to retain salt, this is usually not indicated in 11-beta deficiency because it may worsen high blood pressure or low potassium [1][3]. You should never start or stop any medication without discussing it with your treating clinician. If glucocorticoids aren’t enough to control your blood pressure, your doctor may prescribe specific blood pressure medications to counteract the excess DOC [3].
For 17-alpha hydroxylase deficiency: Management principles include specialist-directed glucocorticoid treatment to suppress ACTH and DOC, as well as blood-pressure and potassium management [7]. Additionally, because of the lack of sex steroids, care involves individualized sex-hormone replacement to support puberty and bone health, with discussions about gonadal and fertility considerations where relevant [16][17].
Adrenal Crisis and Sick Day Safety
Because these conditions impair cortisol production, you may be at risk for a life-threatening condition called an adrenal crisis when your body is under physical stress [1]. It is critical to:
- Never stop taking your glucocorticoids abruptly.
- Learn “Sick Day Rules”: Ask your endocrinologist for a specific plan. You will likely need to double or triple your oral glucocorticoid dose during illness, fever, or physical trauma [15].
- Keep an emergency injection kit: You must have access to injectable hydrocortisone and know how to use it if you are vomiting, unable to keep pills down, or severely injured [1].
- Wear a medical alert ID: This tells emergency responders you are steroid-dependent and need immediate stress-dose hydrocortisone [15].
- Seek urgent care: Go to the emergency room for persistent vomiting/diarrhea, fainting, severe weakness, confusion, or suspected adrenal crisis [1].
Common questions in this guide
What is the main difference between 11-beta and 21-hydroxylase deficiency in CAH?
Can 11-beta hydroxylase deficiency cause high blood pressure?
Which tests distinguish 11-beta from 21-hydroxylase deficiency?
How is 17-alpha hydroxylase deficiency different from the other CAH types?
What treatments may be used for rare CAH enzyme deficiencies?
How can someone with CAH prepare for an adrenal crisis?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Could genetic testing help confirm which enzyme is affected?
Blood pressure monitoring
Would my blood pressure and potassium need regular monitoring?
Adrenal crisis safety
What should I do if I am vomiting and cannot keep pills down?
Related questions
Show more
Get notified when new evidence is published on Congenital adrenal hyperplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Genetics and Pathophysiology of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Yang M, White PC
The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S1-S12 doi:10.1210/clinem/dgae535.
PMID: 39836621 - 2
A Greek girl with 11β-hydroxylase deficiency due to compound heterozygosity for two novel mutations in CYP11B1 gene.
Marakaki C, Papadopoulou A, Karapanou O, et al.
Endocrinology, diabetes & metabolism case reports 2015; (2015()):150074 doi:10.1530/EDM-15-0074.
PMID: 26525354 - 3
Rare types of congenital adrenal hyperplasia: report of five children with 11β-hydroxylase deficiency including pathogenic and novel CYP11B1 variants.
Bala A, Banerjee S, George A, et al.
Archives of endocrinology and metabolism 2026; (70(5)):e260073 doi:10.20945/2359-4292-2026-0073.
PMID: 42429691 - 4
[Steroid 21-hydroxylase deficiency, the most frequent cause of congenital adrenal hyperplasia].
Doleschall M, Török D, Mészáros K, et al.
Orvosi hetilap 2018; (159(7)):269-277 doi:10.1556/650.2018.30986.
PMID: 29429350 - 5
The combination of a novel 2 bp deletion mutation and p.D63H in CYP11B1 cause congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency.
Long Y, Han S, Zhang X, et al.
Endocrine journal 2016; (63(3)):301-10 doi:10.1507/endocrj.EJ15-0433.
PMID: 26806323 - 6
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis.
Miller WL
European journal of endocrinology 2018; (179(3)):R125-R141.
PMID: 29880708 - 7
17α Hydroxylase/17,20 lyase deficiency: clinical features and genetic insights from a large Turkey cohort.
Siklar Z, Camtosun E, Bolu S, et al.
Endocrine 2024; (85(3)):1407-1416 doi:10.1007/s12020-024-03962-6.
PMID: 39020240 - 8
Precocious puberty in male with hypertension and hypokalemia; a definite diagnostic clue for 11β hydroxylase deficiency CAH.
Pande M, Patra S, Katam KK, Darshini S D
Endocrinology, diabetes & metabolism case reports 2025; (2025(2)).
PMID: 40192663 - 9
Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Choi JH, Kim GH, Yoo HW
Annals of pediatric endocrinology & metabolism 2016; (21(1)):1-6 doi:10.6065/apem.2016.21.1.1.
PMID: 27104172 - 10
Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.
Khattab A, Haider S, Kumar A, et al.
Proceedings of the National Academy of Sciences of the United States of America 2017; (114(10)):E1933-E1940 doi:10.1073/pnas.1621082114.
PMID: 28228528 - 11
Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia.
Wang W, Han R, Yang Z, et al.
The Journal of steroid biochemistry and molecular biology 2021; (211()):105899 doi:10.1016/j.jsbmb.2021.105899.
PMID: 33864926 - 12
Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic.
Auchus RJ
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):71-78 doi:10.1016/j.jsbmb.2016.02.002.
PMID: 26862015 - 13
17α-Hydroxylase/17,20-lyase Deficiency (17-OHD): A Meta-analysis of Reported Cases.
Willemsen AL, Torpy DJ, De Sousa SMC, et al.
The Journal of clinical endocrinology and metabolism 2025; (110(4)):e1261-e1271 doi:10.1210/clinem/dgae773.
PMID: 39500362 - 14
Clinical and Genetic Characteristics of Patients with Common and Rare Types of Congenital Adrenal Hyperplasia: Novel Variants in STAR and CYP17A1.
Koprulu O, Ozkan B, Acar S, et al.
Sisli Etfal Hastanesi tip bulteni 2022; (56(2)):291-298 doi:10.14744/SEMB.2021.28044.
PMID: 35990289 - 15
Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Nokoff NJ, Buchanan C, Barker JM
The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S13-S24 doi:10.1210/clinem/dgae563.
PMID: 39836622 - 16
Clinical, biochemical and genetic characteristics of children with congenital adrenal hyperplasia due to 17α-hydroxylase deficiency.
Asirvatham AR, Balachandran K, Jerome P, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2020;.
PMID: 32651986 - 17
Clinical Characteristics and Follow-up Course of 17α-Hydroxylase/17,20-Lyase Deficiency in Korea: the OUTSPREAD Multicenter Study.
Kim KY, Cho SY, Kim MJ, et al.
Endocrinology and metabolism (Seoul, Korea) 2026; doi:10.3803/EnM.2025.2703.
PMID: 42093359
This page is for informational purposes only and does not constitute medical advice. Your endocrinologist or genetics specialist should interpret your hormone tests and create your medication and emergency plan.